Gene: CCDC85B
Official Full Name: coiled-coil domain containing 85Bprovided by HGNC
Gene Summary: Hepatitis delta virus (HDV) is a pathogenic human virus whose RNA genome and replication cycle resemble those of plant viroids. Delta-interacting protein A (DIPA), a cellular gene product, has been found to have homology to hepatitis delta virus antigen (HDAg). DIPA interacts with the viral antigen, HDAg, and can affect HDV replication in vitro. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02404 | CCDC85B Knockout cell line (HeLa) | Human | CCDC85B | 1:3~1:6 | Negative | Online Inquiry |
KO02405 | CCDC85B Knockout cell line (HCT 116) | Human | CCDC85B | 1:2~1:4 | Negative | Online Inquiry |
KO02406 | CCDC85B Knockout cell line (HEK293) | Human | CCDC85B | 1:3~1:6 | Negative | Online Inquiry |
KO02407 | CCDC85B Knockout cell line (A549) | Human | CCDC85B | 1:3~1:4 | Negative | Online Inquiry |
CCDC85B Gene Knockout Cell Lines are genetically engineered cell lines designed to specifically disrupt the CCDC85B gene, a critical player in various cellular processes, including cell adhesion and signal transduction pathways. These knockout cell lines serve as valuable tools for researchers seeking to investigate the functional role of CCDC85B in cellular systems and its implications in disease states, particularly in cancer and developmental disorders.
The mechanism of action involves the targeted deletion of the CCDC85B gene using advanced gene-editing techniques such as CRISPR/Cas9. This precise manipulation allows for the assessment of gene function in cellular contexts, enabling researchers to elucidate the downstream effects of gene knockout on cellular behavior, proliferation, and differentiation. As such, the CCDC85B knockout cell lines provide an experimental model to study gene function in a controlled environment, paving the way for innovative discoveries.
Scientifically, these cell lines are significant as they facilitate research into gene-gene interactions, pathways influenced by CCDC85B, and potential therapeutic targets. Their application spans across fundamental and applied biology, including drug discovery, molecular diagnostics, and therapeutic development. Compared to other methods of gene disruption, the use of knockout cell lines provides a robust and reproducible platform that simplifies the investigation of gene function in a variety of biological contexts.
One of the distinct advantages of the CCDC85B Gene Knockout Cell Lines is their versatility for use in high-throughput screening applications, allowing researchers to quickly evaluate the biological effects of potential therapeutic compounds. Additionally, their specificity in targeting CCDC85B reduces off-target effects, providing greater confidence in experimental outcomes compared to traditional pharmacological inhibitors.
For researchers and clinicians, these knockout cell lines are invaluable resources that enhance the understanding of gene function and its implications in health and disease. Utilization of the CCDC85B Gene Knockout Cell Lines can accelerate the pace of discovery in human biology and disease mechanisms, ultimately contributing to the development of novel therapeutic strategies.
Our company has a longstanding commitment to providing high-quality biological research tools, with expertise in genetic engineering and cell line development. We strive to support the scientific community by offering innovative products that empower researchers to unlock new dimensions of biological understanding.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.